Fas/FasL in the immune pathogenesis of severe aplastic anemia. 2014

C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.

Fas/FasL protein expression of bone marrow hematopoietic cells was investigated in severe aplastic anemia (SAA) patients. Fas expression was evaluated in CD34(+), GlycoA(+), CD33(+), and CD14(+) cells labeled with monoclonal antibodies in newly diagnosed and remission SAA patients along with normal controls. FasL expression was evaluated in CD8(+) cells in the same manner. In CD34(+) cells, Fas expression was significantly higher in the newly diagnosed SAA group (46.59 ± 27.60%) than the remission (6.12 ± 3.35%; P < 0.01) and control (8.89 ± 7.28%; P < 0.01) groups. In CD14(+), CD33(+), and GlycoA(+) cells, Fas levels were significantly lower in the newly diagnosed SAA group (29.29 ± 9.23, 46.88 ± 14.30, and 15.15 ± 9.26%, respectively) than in the remission (47.23 ± 31.56, 67.22 ± 34.68, and 43.56 ± 26.85%, respectively; P < 0.05) and normal control (51.25 ± 38.36, 72.06 ± 39.88, 50.38 ± 39.88%, respectively; P < 0.05) groups. FasL expression of CD8(+) cells was significantly higher in the newly diagnosed SAA group (89.53 ± 45.68%) than the remission (56.39 ± 27.94%; P < 0.01) and control (48.63 ± 27.38%; P <0.01) groups. No significant differences were observed between the remission and control groups. FasL expression in CD8(+) T cells was significantly higher in newly diagnosed patients, and CD34(+), CD33(+), CD14(+), and GlycoA(+) cells all showed Fas antigen expression. The Fas/FasL pathway might play an important role in excessive hematopoietic cell apoptosis in SAA bone marrow. Furthermore, CD34(+) cells are likely the main targets of SAA immune injury.

UI MeSH Term Description Entries
D008297 Male Males
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D005260 Female Females
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016827 CD8 Antigens Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. T8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions. Antigens, CD8,Leu-2 Antigens,T8 Antigens, T-Cell,CD8 Antigen,Antigen, CD8,Antigens, Leu-2,Antigens, T-Cell T8,Leu 2 Antigens,T-Cell T8 Antigens,T8 Antigens, T Cell

Related Publications

C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
July 2018, Immunological investigations,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
January 1979, Haematology and blood transfusion,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
February 2006, Zhonghua er ke za zhi = Chinese journal of pediatrics,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
July 2019, Zhonghua yi xue za zhi,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
October 1981, Seminars in hematology,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
June 1966, Problemy gematologii i perelivaniia krovi,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
June 1985, The Tokai journal of experimental and clinical medicine,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
December 1974, Haematologica,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
C Y Liu, and R Fu, and H Q Wang, and L J Li, and H Liu, and J Guan, and T Wang, and W W Qi, and E B Ruan, and W Qu, and G J Wang, and H Liu, and Y H Wu, and J Song, and L M Xing, and Z H Shao
December 2019, Hematology (Amsterdam, Netherlands),
Copied contents to your clipboard!